Determination of genotoxic nitrosamines in Valsartan with gas chromatography and mass spectrometry
Applications | 2019 | Thermo Fisher ScientificInstrumentation
GC/MSD, HeadSpace, GC/SQ
IndustriesPharma & Biopharma
ManufacturerThermo Fisher Scientific
Key wordsvalsartan, ndma, fda, ndea, nitrosamines, suitability, sim, genotoxic, injection, dmf, thermo, dmso, timed, drug, scientific, solution, inlet, splitless, were, recommended, parameters, method, commercially, detection, analytical, test, dcm, standard, prepared, headspace, mode, nitrosodimethylamine, liner, transfer, line, dissolving, methods, triplus, source, incubation, final, using, according, used, couled, jinshui, weighinh, sample, described, quantification
Similar PDF
Determination of genotoxic nitrosamines in Valsartan with gas chromatography and mass spectrometry
2019|Thermo Fisher Scientific|Applications
APPLICATION NOTE 21922 Determination of genotoxic nitrosamines in Valsartan with gas chromatography and mass spectrometry Authors Introduction Yanggang Zhang, Jinshui Che and Shen Wang Thermo Fisher Scientific, Shanghai, China Valsartan is a widely used anti-hypertensive drug known to reduce human…
Key words
valsartan, valsartanndma, ndmafda, fdandea, ndeanitrosamines, nitrosaminessuitability, suitabilitysim, simgenotoxic, genotoxicinjection, injectiondmf, dmfthermo, thermodmso, dmsotimed, timeddrug, drugscientific
Overcoming the challenges of nitrosamine impurities in drugs
2020|Thermo Fisher Scientific|Others
CASE STUDY 73263 Overcoming the challenges of nitrosamine impurities in drugs What pharmaceutical QA/QC laboratories need to know: Advanced GC-MS capabilities for cGMP nitrosamine testing Why we need to analyze nitrosamine impurities in drugs Unacceptable levels of nitrosamine impurities were…
Key words
min, minndma, ndmandea, ndeanitrosamine, nitrosamineneipa, neipatime, timetemperature, temperatureimpurities, impuritiesorbitrap, orbitrapaquisition, aquisitionmass, massexactive, exactivesource, sourceloop, loopkpa
Overcoming the challenges of nitrosamine impurities in drugs
2020|Thermo Fisher Scientific|Technical notes
CASE STUDY 73263 Overcoming the challenges of nitrosamine impurities in drugs What pharmaceutical QA/QC laboratories need to know: Advanced GC-MS capabilities for cGMP nitrosamine testing Why we need to analyze nitrosamine impurities in drugs Unacceptable levels of nitrosamine impurities were…
Key words
min, minndma, ndmandea, ndeanitrosamine, nitrosamineneipa, neipatime, timetemperature, temperatureimpurities, impuritiesorbitrap, orbitrapaquisition, aquisitionmass, massexactive, exactivesource, sourceloop, loopkpa
Nitrosamine Impurities Application Guide - Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products
2020|Agilent Technologies|GuidesPresentations
Nitrosamine Impurities Application Guide Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products Sartan-Based Losartan Valsartan Candesartan Telmisartan Metformin Ranitidine Nitrosamines are formed by chemical reactions that occur during API manufacturing whether from starting materials, intermediates, reactants, reuse…
Key words
back, backndma, ndmaneipa, neipafda, fdandea, ndeandipa, ndipandba, ndbanitrosamine, nitrosaminemetformin, metforminintroduction, introductionapi, apivalsartan, valsartanbest, bestquant, quantdichloromethan